

[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
[ Tue, Nov 07th 2023
] - WOPRAI
Evan Seigerman Maintained (VRTX) at Buy with Increased Target to $415 on, Nov 7th, 2023
Evan Seigerman of BMO Capital, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Buy with Increased Target from $389 to $415 on, Nov 7th, 2023.
Evan has made no other calls on VRTX in the last 4 months.
There are 12 other peers that have a rating on VRTX. Out of the 12 peers that are also analyzing VRTX, 2 agree with Evan's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Matthew Harrison of "Morgan Stanley" Maintained at Hold with Increased Target to $359 on, Monday, October 9th, 2023
- Whitney Ijem of "Canaccord Genuity" Maintained at Hold with Increased Target to $315 on, Monday, August 7th, 2023
These are the ratings of the 10 analyists that currently disagree with Evan
- Eric Schmidt of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $370 on, Tuesday, October 17th, 2023
- Robyn Karnauskas of "Truist Securities" Reiterated at Strong Buy and Held Target at $456 on, Wednesday, October 4th, 2023
- William Pickering of "Bernstein" Maintained at Buy with Increased Target to $390 on, Wednesday, August 2nd, 2023
- Gena Wang of "Barclays" Maintained at Buy with Increased Target to $399 on, Wednesday, August 2nd, 2023
- Hartaj Singh of "Oppenheimer" Reiterated at Buy and Held Target at $410 on, Wednesday, August 2nd, 2023
- Mohit Bansal of "Wells Fargo" Maintained at Buy with Increased Target to $425 on, Wednesday, August 2nd, 2023
- Phil Nadeau of "TD Cowen" Maintained at Buy with Increased Target to $370 on, Wednesday, August 2nd, 2023
- Liisa Bayko of "Evercore ISI Group" Maintained at Buy and Held Target at $245 on, Tuesday, August 1st, 2023
- Colin Bristow of "UBS" Maintained at Strong Buy with Increased Target to $424 on, Monday, July 24th, 2023
- Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $400 on, Friday, July 21st, 2023
Contributing Sources